CME: Promotion vs Education

Pharmaceutical companies provide over half the financial support and funding for continuing medical education (CME) programs. In 2004, the industry spent over $1 Billion...

Fat Acomplia?

Occasionally, I predict the next frontier in pharmaceutical marketing. Back in September, 2005, for example, I predicted that "sleep aid" DTC (direct-to-consumer) advertising would...

Two Sources of Zocor

As reported in the Philadelphia Inquirer:"This week, Merck & Co. Inc.'s patent on the No. 2 cholesterol drug Zocor will expire, clearing the way...

2nd Annual Medical Device and Diagnostics Marketing Compliance Congress

Critical Updates on Enforcement Actions, Criminal and Civil Liability and Compliance Tactics Regarding Advertising, Off-Label Promotion and Fraud & Abuse

2nd Annual Medical Device and Diagnostics Marketing Compliance Congress

Critical Updates on Enforcement Actions, Criminal and Civil Liability and Compliance Tactics Regarding Advertising, Off-Label Promotion and Fraud & Abuse

Behavioral Targeting: RJ vs JP

Just when you thought it was safe to go back in the water...bam! In this case, the water is tracking consumer website visits for...

4th Annual Pharmaceutical Product Complaints

Benchmark Against 12 Industry Approaches for Effective Classification and Handling of Product Complaints

Blockbuster or BallBuster?

Erectile dysfuntion (ED) drugs -- Viagra, Cialis, Levitra -- are in the news again. It seems that ED drug marketers have retooled their...

Sales Force Effectiveness

I attended Pharmaceutical Executive's 1st Annual Marketing and Sales Summit today and sat in on a few interesting presentations related to sales force effectiveness....

Medical Device DTC: What’s Up With That?

Medical Device DTC stats was the topic of an interesting discussion thread last week on the Pharma Marketing Forum -- a good place to...